Vaccine injection technique and reactogenicity-Evidence for practice

Vaccine

Volumn 26, Issue 50, 2008, Pages 6299-6304

  Petousis Harris, Helen ^a  

^a Faculty of Medical and Health Sciences School of Population Health   (New Zealand)

Author keywords

Intramuscular injections; Reactogenicity; Vaccine administration

Indexed keywords

PROCAINE PENICILLIN; VACCINE;

ASPIRATION; BUTTOCK; DELTOID MUSCLE; GANGRENE; HEALTH CARE POLICY; HUMAN; IMMUNOGENICITY; INJECTION SITE; INJECTION SITE REACTION; MEDICAL PRACTICE; NEEDLE; PRIORITY JOURNAL; REVIEW; THIGH;

CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; VACCINATION; VACCINES;

EID: 55749105698     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.052     Document Type: Review

References (44)

1. Warren B.L. Intramuscular injection angle: evidence for practice?. Nursing Praxis in New Zealand 18 2 (2002) 42-51
2. Zuckerman J.N. The importance of injecting vaccines into muscle. Different patients need different needle sizes. British Medical Journal (BMJ) 321 7271 (2000) 1237-1238 [comment]
3. Poirier M.K., Poland G.A., and Jacobson R.M. Parameters potentially affecting interpretation of immunogenicity and efficacy data in vaccine trials: are they adequately reported?. Vaccine 14 1 (1996) 25-27
4. Plotkin S.A., Orrenstein W.A., and Offit P. Vaccines. 4th ed. (2004), Saunders, Philadelphia p. 94
5. Mark A., Carlsson R.M., and Granstrom M. Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. Vaccine 17 15-16 (1999) 2067-2072
6. Carlsson R.-M., Claesson B.A., Kayhty H., Selstam U., and Iwarson S. Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine. Vaccine 18 5-6 (2000) 468-478
7. Cook I.F., Pond D., and Hartel G. Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine 25 25 (2007) 4767-4774
8. Cook I.F., Barr I., Hartel G., Pond D., and Hampson A.W. Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine 24 13 (2006) 2395-2402
9. Gilles F.H., and French J.H. Postinjection sciatic nerve palsies in infants and children. Journal of Pediatrics 58 (1961) 195-204
10. Bergeson P.S., Singer S.A., and Kaplan A.M. Intramuscular injections in children. Pediatrics 70 6 (1982) 944-948
11. Cook I.F., and Murtagh J. Ventrogluteal area-a suitable site for intramuscular vaccination of infants and toddlers. Vaccine 24 13 (2006) 2403-2408
12. Baraff L.J., Cody C.L., and Cherry J.D. DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics 73 1 (1984) 31-36
13. Tozzi A.E., Ciofi degli Atti M.L., Wassilak S.G., Salmaso S., Panei P., Anemona A., et al. Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines. Vaccine 16 2-3 (1998) 320-322
14. Cook I.F., and Murtagh J. Comparative reactogenicity and parental acceptability of pertussis vaccines administered into the ventrogluteal area and anterolateral thigh in children aged 2, 4, 6 and 18 months. Vaccine 21 23 (2003) 3330-3334
15. Tapiainen T., Cherry J.D., and Heininger U. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants. Vaccine 23 43 (2005) 5106-5112
16. Ipp M.M., Gold R., Goldbach M., Maresky D.C., Saunders N., Greenberg S., et al. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length. Pediatrics 83 5 (1989) 679-682 [comment]
17. Cook I.F., and Murtagh J. Needle length required for intramuscular vaccination of infants and toddlers. An ultrasonographic study. Australian Family Physician 31 3 (2002) 295-297
18. Groswasser J., Kahn A., Bouche B., Hanquinet S., Perlmuter N., and Hessel L. Needle length and injection technique for efficient intramuscular vaccine delivery in infants and children evaluated through an ultrasonographic determination of subcutaneous and muscle layer thickness. Pediatrics 100 3 Pt 1 (1997) 400-403
19. Davenport J.M. A systematic review to ascertain whether the standard needle is more effective than a longer or wider needle in reducing the incidence of local reaction in children receiving primary immunization. Journal of Advanced Nursing 46 1 (2004) 66-77
20. Diggle L., and Deeks J. Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial. British Medical Journal 321 7266 (2000) 931-933 [comment]
21. Diggle L., Deeks J.J., and Pollard A.J. Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. British Medical Journal 333 7568 (2006) 571
22. Petousis-Harris H. Intramuscular injection angle: evidence for practice?. Nursing Praxis in New Zealand 18 2 (2002) 52 [letter]
23. Wong D.L. Essentials of pediatric nursing. Whaley & Wong. 5th ed. (1997)
24. Wong D.L., and Whaley L.F. Clinical handbook of pediaric nursing (1986), The C. V. Mosby Company, St. Louis, Toronto 404-405
25. Opperman C.S., and Cassandra K.A. Contemporary pediatric nursing (1998), Mosby
26. Talbert J.L., Haslam R.H., and Haller Jr. J.A. Gangrene of the foot following intramuscular injection in the lateral thigh: a case report with recommendations for prevention. Journal of Pediatrics 70 1 (1967) 110-114
27. Hick J.F., Charboneau J.W., Brakke D.M., and Goergen B. Optimum needle length for diphtheria-tetanus-pertussis inoculation of infants. Pediatrics 84 1 (1989) 136-137
28. Cook I.F., and Murtagh J. Optimal technique for intramuscular injection of infants and toddlers: a randomised controlled trial. Medical Journal of Australia 183 2 (2005) 60-63
29. Ipp M., Sam J., and Parkin P.C. Needle aspiration and intramuscular vaccination. Archives of Pediatrics & Adolescent Medicine 160 4 (2006) 451
30. Beyea S.C., and Nicoll L.H. Back to basics, administering i.m. injections the right way. American Journal of Nursing 96 1 (1996) 34-35 [comment]
31. The Vaccine Administration Task Force. UK guidelines on best practice in vaccine administration (2001), Shire Hall Communications, London
32. Ipp M., Taddia A., Sam J., Goldbach M., and Parkin P.C. Vaccine related pain: randomized controlled trial of two injection techniques. Archives of Disease in Childhood 92 12 (2007) 1105-1108
33. World Health Organisation. Immunisation in Practice. A practical resource guide for healthcare workers (2004), World Health Organisation, Geneva
34. American Academy of Pediatrics. Red book: 2006 report of the committee on infectious diseases. 27th ed. Elk Grove Villiage, IL: American Academy of Pediatrics; 2006.
35. Smith G., and Katsma D. Intramuscular injection mechanics: does experience improve technique? (1998), North American Congress on Biomechanics, University of Waterloo, Waterloo, Ontario, Canada
36. Katsma D., and Smith G. Analysis of needle path during intramuscular injection. Nursing Research 46 5 (1997) 288-292
37. Centre for disease control and prevention, epidemiology and prevention of vaccine preventable diseases. 10th ed. Washington, DC: Public Health Foundation; 2007.
38. Immunization Action Coalition. How to Administer Intramuscular (IM) Injections. Centre for Disease Control and Prevention; 2007. Electronic Source www.vaccineinformation.org. Accessed 27/8/07.
39. Canadian Immunization Guide, 7th ed. Public works and government services Canada. Ontario: Public Health Agency of Canada; 2006.
40. The Australian Immunisation Handbook, 8th ed. Canberra: National Health and Medical Research Council; 2003.
41. Ministry of Health. Immunisation Handbook 2006. Wellington: Ministry of Health; 2006.
42. Anon. A Phase II, Single centre, randomised, observer blind study to evaluate the safety, reactogenicity and immunogenicity of a three-dose regimen of three different meningococcal serogroup B outer membrane vesicle (OMV) vaccines when administered to two cohorts of 8 to 12 year old healthy children. Standard operating procedures (2007), University of Auckland
43. Poland G.A., Borrud A., Jacobson R.M., McDermott K., Wollan P.C., Brakke D., et al. Determination of deltoid fat pad thickness. Implications for needle length in adult immunization. Journal of the American Medical Association 277 21 (1997) 1709-1711
44. Diggle L., and Deeks J. Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial. British Medical Journal 321 7266 (2000) 931-933